Fresh Tracks Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis
Fresh Tracks Therapeutics was a clinical-stage pharmaceutical company focused on developing therapeutics for autoimmune, inflammatory, and debilitating diseases. The company was dissolved in February 2025, following a...
Cyborg Score thesis
Company is no longer operational; historical investment value has been extinguished....
Read the full analyst-debate transcript →Get the Latest Fresh Tracks Therapeutics, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeFresh Tracks Therapeutics, Inc. Overview
Pro stress-test →Fresh Tracks Therapeutics was a clinical-stage pharmaceutical company focused on developing therapeutics for autoimmune, inflammatory, and debilitating diseases. The company was dissolved in February 2025, following a delisting from Nasdaq in December 2023 and subsequent trading on the OTC Pink market.
Strategic Profile
Pro stress-test →The company was formerly known as Brickell Biotech, Inc. and rebranded in September 2022. Prior to dissolution, it aimed to leverage experienced leadership with track records in commercializing first-in-class pharmaceutical products.
Competitive Landscape
Pro stress-test →N/A - Company is dissolved
Industry Context
Fresh Tracks Therapeutics, Inc. operates in Pharmaceuticals.
Key facts
Founded: 1987 · Headquarters: Boulder, US · Employees: N/A · Revenue: N/A · Market cap: N/A